These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32112894)

  • 21. Dissolution Methods to Increasing Discriminatory Power of In Vitro Dissolution Testing for Ibuprofen Free Acid and Its Salts.
    Cristofoletti R; Dressman JB
    J Pharm Sci; 2017 Jan; 106(1):92-99. PubMed ID: 27397434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
    Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
    Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets.
    Shibata H; Yoshida H; Izutsu K; Goda Y
    J Pharm Pharmacol; 2016 Apr; 68(4):467-74. PubMed ID: 27019275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissolution Profiles of Immediate Release Products of Various Drugs in Biorelevant Bicarbonate Buffer: Comparison with Compendial Phosphate Buffer.
    Okamoto N; Higashino M; Yamamoto H; Sugano K
    Pharm Res; 2024 May; 41(5):959-966. PubMed ID: 38653942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissolution Challenges Associated with the Surface pH of Drug Particles: Integration into Mechanistic Oral Absorption Modeling.
    Hens B; Seegobin N; Bermejo M; Tsume Y; Clear N; McAllister M; Amidon GE; Amidon GL
    AAPS J; 2022 Jan; 24(1):17. PubMed ID: 34982285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel technique for intraduodenal administration of drug suspensions/solutions with concurrent pH monitoring applied to ibuprofen formulations.
    Hofmann M; Thieringer F; Nguyen MA; Månsson W; Galle PR; Langguth P
    Eur J Pharm Biopharm; 2019 Mar; 136():192-202. PubMed ID: 30659894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low Buffer Capacity and Alternating Motility along the Human Gastrointestinal Tract: Implications for in Vivo Dissolution and Absorption of Ionizable Drugs.
    Hens B; Tsume Y; Bermejo M; Paixao P; Koenigsknecht MJ; Baker JR; Hasler WL; Lionberger R; Fan J; Dickens J; Shedden K; Wen B; Wysocki J; Loebenberg R; Lee A; Frances A; Amidon G; Yu A; Benninghoff G; Salehi N; Talattof A; Sun D; Amidon GL
    Mol Pharm; 2017 Dec; 14(12):4281-4294. PubMed ID: 28737409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a physiologic bicarbonate buffer system for dissolution characterization of ionizable drugs.
    McNamara DP; Whitney KM; Goss SL
    Pharm Res; 2003 Oct; 20(10):1641-6. PubMed ID: 14620520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation on the possibility of biowaivers for ibuprofen.
    Alvarez C; Núñez I; Torrado JJ; Gordon J; Potthast H; García-Arieta A
    J Pharm Sci; 2011 Jun; 100(6):2343-9. PubMed ID: 21491448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products.
    Liu F; Merchant HA; Kulkarni RP; Alkademi M; Basit AW
    Eur J Pharm Biopharm; 2011 May; 78(1):151-7. PubMed ID: 21255647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the influence of media composition and ionic strength on drug release from commercial immediate-release and enteric-coated aspirin tablets.
    Karkossa F; Klein S
    J Pharm Pharmacol; 2017 Oct; 69(10):1327-1340. PubMed ID: 28703304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matching phosphate and maleate buffer systems for dissolution of weak acids: Equivalence in terms of buffer capacity of bulk solution or surface pH?
    Cristofoletti R; Dressman JB
    Eur J Pharm Biopharm; 2016 Jun; 103():104-108. PubMed ID: 27032508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic understanding of underperforming enteric coated products: Opportunities to add clinical relevance to the dissolution test.
    Amaral Silva D; Davies NM; Doschak MR; Al-Gousous J; Bou-Chacra N; Löbenberg R
    J Control Release; 2020 Sep; 325():323-334. PubMed ID: 32649973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differing disintegration and dissolution rates, pharmacokinetic profiles and gastrointestinal tolerability of over the counter ibuprofen formulations.
    Bjarnason I; Sancak O; Crossley A; Penrose A; Lanas A
    J Pharm Pharmacol; 2018 Feb; 70(2):223-233. PubMed ID: 29238984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 1: Fasted State Conditions.
    Bermejo M; Paixão P; Hens B; Tsume Y; Koenigsknecht MJ; Baker JR; Hasler WL; Lionberger R; Fan J; Dickens J; Shedden K; Wen B; Wysocki J; Löbenberg R; Lee A; Frances A; Amidon GE; Yu A; Salehi N; Talattof A; Benninghoff G; Sun D; Kuminek G; Cavanagh KL; Rodríguez-Hornedo N; Amidon GL
    Mol Pharm; 2018 Dec; 15(12):5454-5467. PubMed ID: 30372084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toward Mechanistic Design of Surrogate Buffers for Dissolution Testing of pH-Dependent Drug Delivery Systems.
    Blechar JA; Al-Gousous J; Wilhelmy C; Postina AM; Getto M; Langguth P
    Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33321933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Level A IVIVC for immediate release tablets confirms in vivo predictive dissolution testing for ibuprofen.
    Cámara-Martinez I; Blechar JA; Ruiz-Picazo A; Garcia-Arieta A; Calandria C; Merino-Sanjuan V; Langguth P; Gonzalez-Alvarez M; Bermejo M; Al-Gousous J; Gonzalez-Alvarez I
    Int J Pharm; 2022 Feb; 614():121415. PubMed ID: 34973409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of
    da Silva Honório T; Simon A; Machado RMC; Rodrigues CR; do Carmo FA; Cabral LM; de Sousa VP
    Curr Pharm Des; 2023; 29(38):3040-3049. PubMed ID: 37957861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphate buffer interferes dissolution of prazosin hydrochloride in compendial dissolution testing.
    Sudaki H; Fujimoto K; Wada K; Sugano K
    Drug Metab Pharmacokinet; 2023 Aug; 51():100519. PubMed ID: 37393739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanistic Deconvolution of Oral Absorption Model with Dynamic Gastrointestinal Fluid to Predict Regional Rate and Extent of GI Drug Dissolution.
    Yu A; Koenigsknecht MJ; Hens B; Baker JR; Wen B; Jackson TL; Pai MP; Hasler W; Amidon GL; Sun D
    AAPS J; 2019 Nov; 22(1):3. PubMed ID: 31712917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.